Davis Polk advised the underwriters in the offering. Hydrofarm Holdings Group, Inc. executed its $310.6 million follow-on public offering of 5,526,861 shares of common stock, which includes 720,894...
Hydrofarm Holdings Group’s $310.6 Million Follow-on Offering
NeuroPace’s $102 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
UiPath’s $1.54 Billion Initial Public Offering
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
Akoya Biosciences’ $151.3 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
Recursion Pharmaceuticals’ $500 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
Alkami Technology’s $180 Million Initial Public Offering
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...
Maravai LifeSciences’s $646.9 Million Secondary Offering
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
Open Lending’s $351.9 Million Secondary Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. The $351.9 million secondary offering of 10,350,000 shares of common stock...
Beam Therapeutics’ $300 Million At-The-Market Offering
Davis Polk advised Jefferies, the sales agent, in the transaction. Beam Therapeutics Inc. executed the at-the-market offering of shares of its common stock for up to a...
ACV Auctions’ $475.8 Million Initial Public Offering
Davis Polk advised representatives of several underwriters in the offering. ACV Auctions Inc. executed the $475.8 million initial public offering of 19,032,500 shares of Class A common...
Levere Holdings’ $250 Million Initial Public Offering
Davis Polk advised the underwriters in the offering. Levere Holdings Corp. executed its initial public offering of 25,000,000 units, for aggregate proceeds of $250 million. Each unit consists...
Corazon Capital V838 Monoceros’ $200 Million Initial Public Offering
Davis Polk advised the sole book-running manager in the offering. Corazon Capital V838 Monoceros Corp. executed its initial public offering of 20,000,000 units, for aggregate proceeds of...